NeuroPace Inc (NPCE) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6412881053
NeuroPace Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 99.99 m USD |
| Gross profit | 77.22 m USD |
| Operating income | -16.34 m USD |
| EBIT | -16.82 m USD |
| Net income | -21.47 m USD |
| Diluted EPS – continuing operations | -0.66 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NeuroPace Inc
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
More stocks
- Chongqing YuXin Pingrui Electronic Co. Ltd. (301107.SZ)
- RBB Bancorp (RBB)
- INTEKPLUS Co. Ltd (064290.KQ)
- Shenzhen Jiang and Associates Creative Design Co Ltd (300668.SZ)
- CPH Chemie und Papier Holding (CPHN.SW)
- Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367.SZ)
- Beijing Haohan Data Technology Co. Ltd. A (688292.SS)
- Beijing Hanyi Innovation Technology Co. Ltd. A (301270.SZ)
- Zhong Fu Tong Co Ltd (300560.SZ)
- Beijing Jingxi Culture&Tourism Co Ltd (000802.SZ)
- ASSEMBLY BIOSCIENCES, INC. (ASMB)
- Petpal Pet Nutrition Technology Co Ltd (300673.SZ)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.